期刊文献+

沈阳地区9050名无偿献血者HTLV-Ⅰ/Ⅱ感染状况调查 被引量:22

Infection status of HTLV-Ⅰ /Ⅱ in 9050 voluntary blood donors in Shenyang
原文传递
导出
摘要 目的人类T淋巴细胞白血病病毒(HTLV-Ⅰ/Ⅱ),是一种复杂的逆转录病毒,呈世界性广泛分布,国内局部地区有相应的报道。本次调查沈阳地区无偿献血人群中人类T淋巴细胞白血病病毒感染状况,为本地区安全用血提供合适的策略。方法对沈阳地区献血人群以国产双抗原夹心法ELISA试剂初检血清中HTLV-Ⅰ/Ⅱ抗体,初检阳性标本再双孔复试,复试阳性标本采用RT-PCR或蛋白印迹法(Westemblot,WB)确证。结果从2013年3月-2013年5月止,共检测无偿献血者9 050份标本,结果检出可疑阳性5份,用RT-PCR或WB确证实验证实全部为阴性,假阳性率为0.06%。结论调查结果表明沈阳地区献血人群属于HTLV-Ⅰ/Ⅱ感染的低发区或非流行区,从血液检测成本效益和安全输血角度综合分析,沈阳地区对预防血液传染HTLV-Ⅰ/Ⅱ策略是对血制品进行滤白处理更合适。 Objective Human T lymphotropic virus ( HTLV - I / II) is a kind of complex retrovirus and widely distributed throughout world. The corresponding information was reported in local area of China. This paper aims to investigate the infection status of human T lymphotropie virus among volunteer blood donors in Sheyang, and provide appropriate strategies for blood safe- ty in this area. Methods HTLV - I / II antibody was detected in blood donors in Shenyang area by home - made double anti- gen sandwich ELISA kit in the first test. The positive blood samples in the first test were re - tested by double - hole retrial method. Then the seropositive samples were confirmed by RT - PCR or Western blot. Results A total of 9050 voluntary blood donors were detected from March to May in 2013, 5 samples were suspected positive, but confirmed negative with RT -PCR or WB, the false positive rate was 0.06%. Conclusion The blood donors belong to the low - incidence and non - epidemic area of HTLV - I / II infection in Shenyang. Based on the analysis of the blood test cost and transfusion safety, leucodepletion treatment may be better to prevent the HTLV - I / II virus infection in blood transfusion.
机构地区 辽宁省血液中心
出处 《中国卫生检验杂志》 北大核心 2014年第4期588-590,共3页 Chinese Journal of Health Laboratory Technology
基金 国家科技重大专项(2012ZX10004702)
关键词 无偿献血者 筛查 人类嗜T淋巴细胞白血病病毒I Voluntary blood donors Screening HTLV - I / II
  • 相关文献

参考文献16

  • 1Tajima K. Epidemiology, clinical features and prevention of HTLV - I infection[J]. ISBT Science Series, 2009, 4(02) : 352 -356.
  • 2Roucoux DF, Murphy EL. The epidemiology and disease outcomes of human T -lymphotropic virus type II[J]. AIDS Rev, 2004, 6(3) : 144 - 154.
  • 3Sonoda S, Li HC, Tajima K. Ethnoepidemiology of HTLV - 1 relat- ed diseases: ~thnic determinants of HTLV - 1 susceptibility and its worldwide dispersal[J]. Cancer Sci, 2011, 102(2) : 295 -301.
  • 4Satake M, Yamaguehi K, Tadokoro K. Current prevalence of HTLV - 1 in Japan as determined by screening of blood donors[J]. J Med Virol, 2012, 84(2): 327-335.
  • 5Kwon SY, Lira AH, Park JY, et al. Seroprevalence of Human T - Lymphotropic Virus Type 1 and 2 in Korean Blood Donors [ J ]. J Med Viral, 2008, 80(10): 1864-1867.
  • 6Lu SC, Chen BH. Seroindeterminate HTLV - 1 prevalen.ce and char- acteristics in blood donors in Taiwan[ J]. Int J Hematol. 2003, 77 (4) : 412 -413.
  • 7Dorsey KA, Moritz ED, Steele WR, et al. A comparison of human immunodeficieney virus, hepatitis C virus, hepatitis B virus, and hu- man T - lymphotropic virus marker rates for directed versus volunteer blood donations to the American Red Cross during 2005 to 2010 [ J ]. Transfusion, 2013, 53(6): 1250-1256.
  • 8Berini CA, Gendler SA, Pascuccio S, et al. Decreasing trends in HTLV - 1/2 but stable HIV - 1 infection among replacement donors in Argentina[J]. J Med Virol, 2010, 82(5) : 873 -877.
  • 9Namen - Lopes MS, Martins ML, Drummond PC, et al. Lookback study of HTLV - 1 and 2 seropositive donors and their recipients in Belo Horizonte, Brazil[J]. Transfus Med, 2009, 19 (4) : 180 - 188.
  • 10Rouet F, Foucher C, Rabier M, et al. Human T - lymphotropic vi- rus type I among blood donors from Guadeloupe: donation, demo- graphic, and biologic characteristics [ J ]. Transfusion, 1999, 39 (6) : 639 -644.

同被引文献99

引证文献22

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部